| __timestamp | Alpine Immune Sciences, Inc. | BioMarin Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 461543000 |
| Thursday, January 1, 2015 | 16054000 | 634806000 |
| Friday, January 1, 2016 | 23316000 | 661905000 |
| Sunday, January 1, 2017 | 10626000 | 610753000 |
| Monday, January 1, 2018 | 28970000 | 696328000 |
| Tuesday, January 1, 2019 | 35847000 | 715007000 |
| Wednesday, January 1, 2020 | 27185000 | 628116000 |
| Friday, January 1, 2021 | 58742000 | 628793000 |
| Saturday, January 1, 2022 | 70243000 | 649606000 |
| Sunday, January 1, 2023 | 80904000 | 746773000 |
| Monday, January 1, 2024 | 747184000 |
In pursuit of knowledge
In the ever-evolving world of biotechnology, research and development (R&D) are the lifeblood of innovation. Over the past decade, BioMarin Pharmaceutical Inc. and Alpine Immune Sciences, Inc. have demonstrated contrasting yet intriguing R&D investment strategies.
BioMarin, a leader in the field, has consistently allocated substantial resources to R&D, with expenditures peaking at approximately $747 million in 2023. This represents a 62% increase from 2014, underscoring their commitment to pioneering therapies. In contrast, Alpine Immune Sciences, a smaller player, has shown a remarkable growth trajectory, with R&D spending surging by over 560% from 2014 to 2023, reaching around $81 million.
These figures highlight the dynamic nature of biotech investments, where both established giants and emerging innovators play crucial roles in shaping the future of healthcare.
R&D Spending Showdown: AbbVie Inc. vs Alpine Immune Sciences, Inc.
Research and Development Expenses Breakdown: Novartis AG vs BioMarin Pharmaceutical Inc.
Research and Development Investment: Sanofi vs Alpine Immune Sciences, Inc.
R&D Insights: How Bristol-Myers Squibb Company and BioMarin Pharmaceutical Inc. Allocate Funds
Comparing Innovation Spending: Zoetis Inc. and BioMarin Pharmaceutical Inc.
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc.
Research and Development: Comparing Key Metrics for Biogen Inc. and Alpine Immune Sciences, Inc.
BioMarin Pharmaceutical Inc. or Pharming Group N.V.: Who Invests More in Innovation?
Analyzing R&D Budgets: BioMarin Pharmaceutical Inc. vs Viridian Therapeutics, Inc.
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Protagonist Therapeutics, Inc.
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Dynavax Technologies Corporation
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and BioCryst Pharmaceuticals, Inc.